Latest Commercialisation News

Archer Materials has progressed its Biochip program by completing the alpha prototype and Stage 1 project with IMEC, now advancing to develop a beta prototype suitable for external use and clinical validation.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

Weebit Nano Ltd (ASX: WBT) has opened a non-underwritten Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 worth of shares at A$4.05 each. The company aims to raise up to A$15 million to support the commercialisation of its Resistive RAM (ReRAM) technology.

BluGlass Limited (ASX: BLG) has entered a A$1.3 million strategic collaboration with a Fortune 500 global data storage company to advance photonics research using its proprietary visible laser technology.

Nexsen Limited (ASX:NXN) has completed its Stage 1 ISO 13485 audit, confirming its Quality Management System (QMS) supports clinical validation and regulatory submissions for its diagnostic products, including StrepSure®. The company is progressing toward full certification and alignment with MDSAP requirements to facilitate global market access.

Noble Helium has raised $12 million through a strongly supported institutional placement to fund its North Rukwa helium exploration in Tanzania, responding to tightening global helium supplies.

Tamboran Resources reports robust and stable gas production from its Shenandoah South 6H well, marking a key milestone ahead of planned gas sales in late 2026.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

Pure Resources Limited has entered a legally binding R&D collaboration with Rice University to develop cutting-edge carbon nanotube fibre thermal management systems using graphite from its Garnet Hills Project. The partnership includes joint intellectual property ownership and a planned $3 million equity placement to fund exploration and downstream initiatives.

Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.

Charger Metals NL advances its lithium and gold exploration with an expanded maiden resource at Medcalf and a striking high-grade gold discovery at Xmas. The company’s projects benefit from strong commodity prices and strategic locations in Australia’s premier mining jurisdictions.